Jiangsu Nhwa Pharmaceutical Co Ltd (002262) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.053x

Based on the latest financial reports, Jiangsu Nhwa Pharmaceutical Co Ltd (002262) has a cash flow conversion efficiency ratio of 0.053x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥425.83 Million ≈ $62.31 Million USD) by net assets (CN¥8.08 Billion ≈ $1.18 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 002262 days of operational coverage to measure how many days the company can operate on defensive assets alone.

Jiangsu Nhwa Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2005–2025)

This chart illustrates how Jiangsu Nhwa Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Jiangsu Nhwa Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Jiangsu Nhwa Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Megacable Holdings S. A. B. de C. V
MX:MEGACPO
0.098x
Colt CZ Group SE
PR:CZG
0.099x
Hercules Capital Inc
NYSE:HTGC
0.036x
Centuri Holdings, Inc.
NYSE:CTRI
-0.040x
China Suntien Green Energy Corp Ltd
SHG:600956
0.093x
Enea S.A.
WAR:ENA
0.071x
Steven Madden Ltd
NASDAQ:SHOO
-0.058x
Dynex Capital Inc
NYSE:DX
0.026x

Annual Cash Flow Conversion Efficiency for Jiangsu Nhwa Pharmaceutical Co Ltd (2005–2025)

The table below shows the annual cash flow conversion efficiency of Jiangsu Nhwa Pharmaceutical Co Ltd from 2005 to 2025. For the full company profile with market capitalisation and key ratios, see 002262 company net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥8.03 Billion
≈ $1.17 Billion
CN¥1.08 Billion
≈ $157.80 Million
0.134x +6.65%
2024-12-31 CN¥7.27 Billion
≈ $1.06 Billion
CN¥916.13 Million
≈ $134.06 Million
0.126x -19.93%
2023-12-31 CN¥6.41 Billion
≈ $938.00 Million
CN¥1.01 Billion
≈ $147.55 Million
0.157x +2.01%
2022-12-31 CN¥5.58 Billion
≈ $817.07 Million
CN¥861.02 Million
≈ $125.99 Million
0.154x +7.85%
2021-12-31 CN¥4.90 Billion
≈ $717.57 Million
CN¥701.12 Million
≈ $102.60 Million
0.143x -52.98%
2020-12-31 CN¥4.11 Billion
≈ $600.76 Million
CN¥1.25 Billion
≈ $182.67 Million
0.304x +258.24%
2019-12-31 CN¥3.60 Billion
≈ $527.50 Million
CN¥305.97 Million
≈ $44.77 Million
0.085x -37.93%
2018-12-31 CN¥2.96 Billion
≈ $432.87 Million
CN¥404.52 Million
≈ $59.19 Million
0.137x -25.59%
2017-12-31 CN¥2.46 Billion
≈ $360.17 Million
CN¥452.35 Million
≈ $66.19 Million
0.184x +40.84%
2016-12-31 CN¥2.12 Billion
≈ $310.80 Million
CN¥277.14 Million
≈ $40.55 Million
0.130x +16.75%
2015-12-31 CN¥1.83 Billion
≈ $267.39 Million
CN¥204.24 Million
≈ $29.89 Million
0.112x -26.13%
2014-12-31 CN¥1.06 Billion
≈ $154.97 Million
CN¥160.24 Million
≈ $23.45 Million
0.151x -34.89%
2013-12-31 CN¥836.21 Million
≈ $122.36 Million
CN¥194.33 Million
≈ $28.44 Million
0.232x +2.88%
2012-12-31 CN¥682.44 Million
≈ $99.86 Million
CN¥154.16 Million
≈ $22.56 Million
0.226x +54.92%
2011-12-31 CN¥556.01 Million
≈ $81.36 Million
CN¥81.08 Million
≈ $11.86 Million
0.146x +9.15%
2010-12-31 CN¥462.56 Million
≈ $67.69 Million
CN¥61.79 Million
≈ $9.04 Million
0.134x -13.66%
2009-12-31 CN¥396.00 Million
≈ $57.95 Million
CN¥61.27 Million
≈ $8.97 Million
0.155x +14.38%
2008-12-31 CN¥343.75 Million
≈ $50.30 Million
CN¥46.50 Million
≈ $6.80 Million
0.135x -57.54%
2007-12-31 CN¥152.39 Million
≈ $22.30 Million
CN¥48.55 Million
≈ $7.10 Million
0.319x +26.12%
2006-12-31 CN¥122.67 Million
≈ $17.95 Million
CN¥30.99 Million
≈ $4.53 Million
0.253x +259.29%
2005-12-31 CN¥125.74 Million
≈ $18.40 Million
CN¥8.84 Million
≈ $1.29 Million
0.070x --

About Jiangsu Nhwa Pharmaceutical Co Ltd

SHE:002262 China Drug Manufacturers - Specialty & Generic
Market Cap
$2.84 Billion
CN¥19.43 Billion CNY
Market Cap Rank
#5189 Global
#970 in China
Share Price
CN¥19.13
Change (1 day)
-1.80%
52-Week Range
CN¥18.97 - CN¥28.92
All Time High
CN¥31.19
About

Jiangsu Nhwa Pharmaceutical Co., LTD engages in research, development, production, and sale of central nervous system products in China. The company offers APIs, solid preparation, water injection, and freeze-dried powder formulations for depression, anxiety disorders, insomnia, severe mental disorders, and neurodegenerative diseases. Its products include sufentanil citrate injection, oxaliplatin… Read more